{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:14:43Z","timestamp":1782738883298,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,20]],"date-time":"2012-04-20T00:00:00Z","timestamp":1334880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s11102-012-0394-8","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T03:51:13Z","timestamp":1334807473000},"page":"319-329","source":"Crossref","is-referenced-by-count":54,"title":["Clinical consequences of Cushing\u2019s syndrome"],"prefix":"10.1007","volume":"15","author":[{"given":"Elena","family":"Valassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,20]]},"reference":[{"key":"394_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","volume":"34","author":"R Pivonello","year":"2005","unstructured":"Pivonello R, Faggiano A, Lombardi G, Colao A (2005) The metabolic syndrome and cardiovascular risk in Cushing\u2019s syndrome. Endocrinol Metab Clin N Am 34:327\u2013339","journal-title":"Endocrinol Metab Clin N Am"},{"key":"394_CR2","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1210\/jc.84.8.2664","volume":"84","author":"AM Colao","year":"1999","unstructured":"Colao AM, Pivonello R, Spiezia R, Faggiano A, Ferone D, Filippella M, Marzullo P, Carbone G, Siciliani M, Lombardi G (1999) Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J Clin Endocrinol Metab 84:2664\u20132672","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR3","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1210\/jc.84.11.3991","volume":"84","author":"SAG Kemink","year":"1999","unstructured":"Kemink SAG, Frijns JTM, Hermus ARMM, Pieters GFFM, Smals AGH, van Marken Lichtenbelt WD (1999) Body composition determined by six different methods in women bilaterally adrenalectomized for treatment of Cushing\u2019s disease. J Clin Endocrinol Metab 84:3991\u20133999","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1359\/jbmr.061010","volume":"22","author":"GM Leong","year":"2007","unstructured":"Leong GM, Abad V, Charmandari E, Reynolds JC, Hill S, Chrousos GP, Nieman LK (2007) Effects of child-and adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-year prospective study into adulthood. J Bone Miner Res 22:110\u2013118","journal-title":"J Bone Miner Res"},{"key":"394_CR5","doi-asserted-by":"crossref","unstructured":"Valassi E, Biller MK, Klibanski A, Misra M (2011) Adipokines and cardiovascular risk in Cushing\u2019s syndrome. Neuroendocrinology (Epub ahead of print)","DOI":"10.1159\/000330416"},{"key":"394_CR6","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","volume":"94","author":"MJ Barahona","year":"2009","unstructured":"Barahona MJ, Sucunza N, Resmini E, Fernandes-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, Farrerons J, Webb SM (2009) Persistent body fat mass and inflammatory marker increase after long-term cure of Cushing\u2019s syndrome. J Clin Endocrinol Metab 94:3365\u20133371","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR7","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1210\/jc.82.8.2542","volume":"82","author":"H Masuzaki","year":"1997","unstructured":"Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanakoa I, Yasuno A, Nishimura H, Yoshimasa Y, Nishi S, Nakao K (1997) Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing\u2019s syndrome. J Clin Endocrinol Metab 82:2542\u20132547","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2265.2003.01987.x","volume":"60","author":"M Kresk","year":"2004","unstructured":"Kresk M, Silha JV, Jezkova J, Hana V, Marek J, Weiss V, Stepan JJ, Murphy LJ (2004) Adipokine levels in Cushing\u2019s syndrome; elevated resistin levels in female patients with Cushing\u2019s syndrome. Clin Endocrinol 60:350\u2013357","journal-title":"Clin Endocrinol"},{"key":"394_CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/eje.1.02329","volume":"156","author":"F Pecori Giraldi","year":"2007","unstructured":"Pecori Giraldi F, Andrioli M, De Marinis L, Bianchi A, Giampietro A, De Martin M, Sacco E, Scacchi M, Pontecorvi F, Cavagnini F (2007) Significant GH deficiency after long-term cure by surgery in adult patients with Cushing\u2019s disease. Eur J Endocrinol 156:233\u2013239","journal-title":"Eur J Endocrinol"},{"key":"394_CR10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2265.2004.02018.x","volume":"60","author":"G Johannsson","year":"2004","unstructured":"Johannsson G, Sunnerhagen KS, Svensson J (2004) Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing\u2019s disease. Clin Endocrinol 60:550\u2013559","journal-title":"Clin Endocrinol"},{"key":"394_CR11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2006.02488.x","volume":"64","author":"MG Burt","year":"2006","unstructured":"Burt MG, Gibney J, Ho KKY (2006) Characterization of the metabolic phenotypes of Cushing\u2019s syndrome and growth hormone deficiency: a study of body composition and energy metabolism. Clin Endocrinol 64:436\u2013443","journal-title":"Clin Endocrinol"},{"key":"394_CR12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jc.2009-0806","volume":"95","author":"SM Webb","year":"2010","unstructured":"Webb SM, Mo D, Lamberts SWJ, Melmed S, Cavagnini F, Giraldi FP, Strasburger CJ, Zimmermann AG, Woodmansee WW, on behalf of the International HypoCCS Advisory Board (2010) Metabolic, cardiovascular and cerebrovascular outcomes in GH-deficient 1 subjects with previous 2 Cushing\u2019s disease or non-functioning pituitary adenoma: a Hypopituitary Control and Complications Study (HypoCCS) analysis. J Clin Endocrinol Metab 95:630\u2013638. doi: 10.1210\/jc.2009-0806","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR13","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","volume":"88","author":"A Faggiano","year":"2003","unstructured":"Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1\u00a0year after disease remission. J Clin Endocrinol Metab 88:2527\u20132533","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR14","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-2007-992813","volume":"39","author":"FP Giraldi","year":"2007","unstructured":"Giraldi FP, Toja PM, De Martin M, Maronati A, Scacchi M, Omboni S, Cavagnini F (2007) Circadian blood pressure profile in patients with active Cushing\u2019s disease and after long-term cure. Horm Metab Res 39:908\u2013914","journal-title":"Horm Metab Res"},{"key":"394_CR15","first-page":"1189","volume":"114","author":"D Simon","year":"1993","unstructured":"Simon D, Goretzki PE, Lollert A, Roher HD (1993) Persistent hypertension after successful adrenal operation. Surgery 114:1189\u20131195","journal-title":"Surgery"},{"key":"394_CR16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/07435800009048601","volume":"26","author":"T Suzuki","year":"2000","unstructured":"Suzuki T, Shibata H, Ando T, Kurihara I, Kobayashi S, Hayashi M, Kawabe H, Saito I, Murai M, Saruta T (2000) Risk factots associated with persistent postoperative hypertension in Cushing\u2019s syndrome. Endocr Res 26:791\u2013795","journal-title":"Endocr Res"},{"key":"394_CR17","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1210\/jc.2008-2694","volume":"94","author":"MB Lodish","year":"2009","unstructured":"Lodish MB, Sinaii N, Patronas N, Batista DL, Keil M, Samuel J, Moran J, Verma S, Popovic J, Stratakis CA (2009) Blood pressure in pediatric patients with Cushing\u2019s s\u00edndrome. J Clin Endocrinol Metab 94:2002\u20132008","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2011.04206.x","volume":"76","author":"PM Toja","year":"2011","unstructured":"Toja PM, Branzi G, Ciambellotti F, Radaelli P, De Martin M, Lonati LM, Scacchi M, Parati G, Cavagnini F, Giraldi FP (2011) Clinical relevance of cardiac structure and function abnormalities in patients with Cushing\u2019s syndrome before and after cure. Clin Endocrinol 76:332\u2013338","journal-title":"Clin Endocrinol"},{"key":"394_CR19","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0735-1097(03)00493-5","volume":"41","author":"ML Muiesan","year":"2003","unstructured":"Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA, Fallo F (2003) Left ventricular structural and functional characteristics in Cushing\u2019s syndrome. J Am Coll Cardiol 41:2275\u20132279","journal-title":"J Am Coll Cardiol"},{"key":"394_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-09-0621","volume":"162","author":"AM Pereira","year":"2010","unstructured":"Pereira AM, Delgado V, Romijn JA, Smit JWA, Bax JJ, Feelders RA (2010) Cardiac dysfunction is reversed upon successful treatment of Cushing\u2019s disease. Eur J Endocrinol 162:331\u2013340","journal-title":"Eur J Endocrinol"},{"key":"394_CR21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1017\/S1047951110000727","volume":"20","author":"PP Bassareo","year":"2010","unstructured":"Bassareo PP, Marras AR, Pasqualucci D, Mercuro G (2010) Increased arterial rigidity in children affected by Cushing\u2019s syndrome after successful surgical cure. Cardiol Young 20:610\u2013614","journal-title":"Cardiol Young"},{"key":"394_CR22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","volume":"163","author":"L Manetti","year":"2010","unstructured":"Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, Ruocco L, Iannelli A, Martino E (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing\u2019s syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163:783\u2013791","journal-title":"Eur J Endocrinol"},{"key":"394_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03343697","volume":"23","author":"LM Fatti","year":"2000","unstructured":"Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM (2000) Markers of activation of coagulation and fibrinolysis in patients with Cushing\u2019s syndrome. J Endocrinol Invest 23:145\u2013150","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"394_CR24","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","volume":"94","author":"B Zaane Van","year":"2009","unstructured":"Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, Fliers E, Gerdes VE, B\u00fcller HR, Brandjes DP (2009) Hypercoagulable state in Cushing\u2019s syndrome: a systematic review. J Clin Endocrinol Metab 94(8):2743\u20132750","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR25","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","volume":"96","author":"DJF Stuijver","year":"2011","unstructured":"Stuijver DJF, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, van Den Berg G, Pererira AM, de Herder WW, Wagenmakers MAEM, Kerstens MN, Zelissen PMJ, Fliers E, Schaper N, Drent ML, Dekkers OM, Gerders VEA (2011) Incidence of venous thromboembolism in patients with Cushing\u2019s syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96:3525\u20133532","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"Valassi E, Santos A, Yaneva M, Toth M, Strasburger CJ, Chanson P, Wass JAH, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SWJ, Tabarin A, Webb S (2011) The European Registry on Cushing\u2019s syndrome (ERCUSYN): two-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165:383\u2013392","journal-title":"Eur J Endocrinol"},{"key":"394_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11102-005-1173-6","volume":"7","author":"T Mancini","year":"2004","unstructured":"Mancini T, Doga M, Mazziotti G, Giustina A (2004) Cushing\u2019s syndrome and bone. Pituitary 7:243\u2013246","journal-title":"Pituitary"},{"key":"394_CR28","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1210\/jc.86.12.5681","volume":"86","author":"E Canalis","year":"2001","unstructured":"Canalis E, Giustina A (2001) Glucocorticoid-induced osteoporosis: summary of a workshop. J Clin Endocrinol Metab 86:5681\u20135685","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02067","volume":"154","author":"C Kristo","year":"2006","unstructured":"Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing\u2019s syndrome: a prospective, long-term study. Eur J Endocrinol 154:109\u2013118","journal-title":"Eur J Endocrinol"},{"key":"394_CR30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2265.1992.tb01437.x","volume":"36","author":"PJ Manning","year":"1992","unstructured":"Manning PJ, Evans MC, Reid IR (1992) Normal bone density following cure of Cushing\u2019s syndrome. Clin Endocrinol 36:229\u2013234","journal-title":"Clin Endocrinol"},{"key":"394_CR31","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1210\/jc.80.10.2859","volume":"80","author":"AR Hermus","year":"1995","unstructured":"Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing\u2019s syndrome. J Clin Endocrinol Metab 80:2859\u20132865","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2265.2003.01713.x","volume":"58","author":"C Somma Di","year":"2003","unstructured":"Di Somma C, Pivonello R, Loche R, Faggiano A, Klain M, Salvatore M, Lombardi G, Colao A (2003) Effect of 2\u00a0years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing\u2019s disease: a prospective study. Clin Endocrinol 58:302\u2013308","journal-title":"Clin Endocrinol"},{"key":"394_CR33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1015362822901","volume":"4","author":"A Faggiano","year":"2001","unstructured":"Faggiano A, Pivonello R, Filippella M, Di Somma C, Orio F, Lombardi G, Colao A (2001) Spine abnormalities and damage in patients cured from Cushing\u2019s disease. Pituitary 4:153\u2013161","journal-title":"Pituitary"},{"key":"394_CR34","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1359\/jbmr.090505","volume":"24","author":"MJ Barahona","year":"2009","unstructured":"Barahona MJ, Sucunza N, Resmini E, Fernandez-Real M, Ricart W, Moreno-Navarrete JM, Puig T, Wagner AM, Rodriguez-Espinosa J, Farrerons J, Webb SM (2009) Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing\u2019s syndrome. J Bone Min Res 24:1841\u20131846","journal-title":"J Bone Min Res"},{"key":"394_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1460051","volume":"146","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Lindholm J, Jorgensen JO, Hagen C, Hoek HC, Laurberg P, Rejnmark L, Brixen K, Kristensen LO, Feldt-Rasmussen U, Mosekilde L (2002) Increased risk of osteoporotic fractures in patients with Cushing\u2019s syndrome. Eur J Endocrinol 146:51\u201356","journal-title":"Eur J Endocrinol"},{"key":"394_CR36","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/jc.2002-021494","volume":"88","author":"A Faggiano","year":"2003","unstructured":"Faggiano A, Pivonello R, Melis D, Filippella M, Di Somma C, Petretta M, Lombardi G, Colao A (2003) Nephrolithiasis in Cushing\u2019s disease: prevalence, etiopathogenesis, and modification after disease cure. J Clin Endocrinol Metab 88:2076\u20132080","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF03343978","volume":"25","author":"A Faggiano","year":"2002","unstructured":"Faggiano A, Pivonello R, Melid D, Alfieri R, Filippella M, Spagnuolo G, Salvatore F, Lombardi G, Colao A (2002) Evaluation of circulating levels and renal clearance of natural aminoacids in patients with Cushing\u2019s disease. J Endocrinol Invest 25:142\u2013151","journal-title":"J Endocrinol Invest"},{"key":"394_CR38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.jrn.2010.10.015","volume":"21","author":"NM Maalouf","year":"2011","unstructured":"Maalouf NM (2011) Metabolic syndrome and the genesis of uric acid stones. J Ren Nutr 21:128\u2013131","journal-title":"J Ren Nutr"},{"key":"394_CR39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S1355617700611037","volume":"6","author":"H Forget","year":"2000","unstructured":"Forget H, Lacroix A, Somma M, Cohen H (2000) Cognitive decline in patients with Cushing\u2019s syndrome. J Int Neuropsychol Soc 6:20\u201329","journal-title":"J Int Neuropsychol Soc"},{"key":"394_CR40","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","volume":"32","author":"MN Starkman","year":"1992","unstructured":"Starkman MN, Gebarski SS, Berent S, Schteingart DE (1992) Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing\u2019s syndrome. Biol Psychiatry 32:756\u2013765","journal-title":"Biol Psychiatry"},{"key":"394_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bandc.2009.02.013","volume":"71","author":"K Michaud","year":"2009","unstructured":"Michaud K, Forget H, Cohen H (2009) Chronic glucocorticoid hypersecretion in Cushing\u2019s syndrome exacerbates cognitive aging. Brain Cogn 71:1\u20138","journal-title":"Brain Cogn"},{"key":"394_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2008.03355.x","volume":"70","author":"J Le\u00f3n-Carri\u00f3n","year":"2009","unstructured":"Le\u00f3n-Carri\u00f3n J, Atutxa AM, Mangas MA, Soto-Moreno A, Pumar A, Le\u00f3n Justel A, Mart\u00edn Rodr\u00edguez JF, Venegas E, Dominguez-Morales MR, Leal-Cerro A (2009) A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clin Endocrinol (Oxf) 70:1\u20138","journal-title":"Clin Endocrinol (Oxf)"},{"key":"394_CR43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000029054","volume":"31","author":"N Sonino","year":"1998","unstructured":"Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F (1998) Clinical correlates of major depression in Cushing\u2019s disease. Psychopathology 31:302\u2013306","journal-title":"Psychopathology"},{"key":"394_CR44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00006842-200111000-00018","volume":"63","author":"MN Starkman","year":"2001","unstructured":"Starkman MN, Giordani B, Berent S, Shork MA, Schteingart DE (2001) Elevated cortisol levels in Cushing\u2019s disease are associated with cognitive decrement. Psychosom Med 63:985\u2013993","journal-title":"Psychosom Med"},{"key":"394_CR45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2006.11.007","volume":"101","author":"MN Starkman","year":"2007","unstructured":"Starkman MN, Giordani B, Gebarski SS (2007) Improvement in mood and ideation associated with increase in right caudate volume. J Affect Disord 101:139\u2013147","journal-title":"J Affect Disord"},{"key":"394_CR46","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1210\/jc.87.5.1949","volume":"87","author":"I Bourdeau","year":"2002","unstructured":"Bourdeau I, Bard C, No\u00ebl B, Leclerc I, Cordeau MP, B\u00e9lair M, Lesage J, Lafontaine L, Lacroix A (2002) Loss of brain volume in endogenous Cushing\u2019s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87:1949\u20131954","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0404.1993.tb04075.x","volume":"87","author":"M Mauri","year":"1993","unstructured":"Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R, Nappi G (1993) Memory impairment in Cushing\u2019s disease. Acta Neurol Scand 87:52\u201355","journal-title":"Acta Neurol Scand"},{"key":"394_CR48","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1210\/jc.82.3.912","volume":"82","author":"LD Dorn","year":"1997","unstructured":"Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912\u2013919","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR49","first-page":"21","volume":"13","author":"JN Hook","year":"2007","unstructured":"Hook JN, Giordani B, Schteingart DE, Guire K, Giles J, Ryan K, Gebarski SS, Langenecker SA, Starkman MN (2007) Patterns of cognitive change over time and relationship to age following successful treatment of Cushing\u2019s disease. J Int Neuropsychol Soc 13:21\u201329","journal-title":"J Int Neuropsychol Soc"},{"key":"394_CR50","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/jc.2004-2488","volume":"90","author":"DP Merke","year":"2005","unstructured":"Merke DP, Giedd JN, Keil MF, Mehlinger SL, Wiggs EA, Holzer S, Rawson E, Vaituzis AC, Stratakis CA, Chrousos GP (2005) Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing\u2019s syndrome. J Clin Endocrinol Metab 90:2531\u20132536","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2009-2363","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BSA, Wassenaar MJE, Middelkoop HAM, Pereira AM, Romijn JA (2010) Subtle cognitive impairment in patients with long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95:1\u201316","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/jc.2011-2231","volume":"97","author":"E Resmini","year":"2012","unstructured":"Resmini E, Santos A, G\u00f3mez-Anson B, Vives Y, Pires P, Crespo I, Portella MJ, Delago MJ, Barahona MJ, Webb SM (2012) Verbal and visual memory performance and hippocampal volumes, measured by 3-tesla magnetic resonance imaging, in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 97:663\u2013671","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR53","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Biermasz NR, Middlekoop HAM, van der Mast RC, Romijn JA, Pereira AM (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95:E129\u2013E141","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1998.00528.x","volume":"49","author":"N Sonino","year":"1998","unstructured":"Sonino N, Fava GA (1998) Psychological aspects of endocrine disease. Clin Endocrinol (Oxf) 49:1\u20137","journal-title":"Clin Endocrinol (Oxf)"},{"key":"394_CR55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","volume":"6","author":"MD Johnson","year":"2003","unstructured":"Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81\u201387","journal-title":"Pituitary"},{"issue":"6","key":"394_CR56","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","volume":"90","author":"MO Aken Van","year":"2005","unstructured":"Van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease. J Clin Endocrinol Metab 90(6):3279\u20133286","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/jc.86.1.117","volume":"86","author":"J Lindholm","year":"2001","unstructured":"Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study. J Clin Endocrinol Metab 86:117\u2013123","journal-title":"J Clin Endocrinol Metab"},{"issue":"447","key":"394_CR58","first-page":"453","volume":"91","author":"JR Lindsay","year":"2006","unstructured":"Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK (2006) Long-term impaired quality of life in Cushing\u2019s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91(447):453","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR59","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1067\/msy.2002.128482","volume":"132","author":"MT Hawn","year":"2002","unstructured":"Hawn MT, Cook D, Deveney C, Sheppard BC (2002) Quality of life after laparoscopic bilateral adrenalectomy for Cushing\u2019s disease. Surgery 132:1064\u20131068","journal-title":"Surgery"},{"key":"394_CR60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002689910020","volume":"24","author":"SK Nagesser","year":"2000","unstructured":"Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ (2000) Long-term results of total adrenalectomy for Cushing\u2019s disease. World J Surg 24:108\u2013113","journal-title":"World J Surg"},{"key":"394_CR61","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","volume":"245","author":"L Pikkarainen","year":"1999","unstructured":"Pikkarainen L, Sane T, Reunanen A (1999) The survival and well-being of patients treated for Cushing\u2019s syndrome. J Intern Med 245:463\u2013468","journal-title":"J Intern Med"},{"key":"394_CR62","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0762","volume":"158","author":"SM Webb","year":"2008","unstructured":"Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, van Aken MO, Pivonello R, Stalla G, Lamberts SWJ, Glusman JE (2008) Evaluation of health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire. Eur J Endocrinol 158:623\u2013630","journal-title":"Eur J Endocrinol"},{"key":"394_CR63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.2003.01799.x","volume":"59","author":"IA Malik","year":"2003","unstructured":"Malik IA, Foy P, Wallymahmed M, Wilding JP, MacFarlane IA (2003) Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects. Clin Endocrinol (Oxf) 59:75\u201381","journal-title":"Clin Endocrinol (Oxf)"},{"key":"394_CR64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1460067","volume":"146","author":"U Feldt-Rasmussen","year":"2002","unstructured":"Feldt-Rasmussen U, Abs R, Bengstsson BA, Bennmarker H, Bramnert M, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P, Wuster C (2002) Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing\u2019s disease. Eur J Endocrinol 146:67\u201374","journal-title":"Eur J Endocrinol"},{"key":"394_CR65","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.sla.0000251578.03883.2f","volume":"245","author":"SK Thompson","year":"2007","unstructured":"Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral adrenalectomy for Cushing\u2019s disease: a 10-year experience. Ann Surg 245:790\u2013794","journal-title":"Ann Surg"},{"key":"394_CR66","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jamcollsurg.2009.02.054","volume":"208","author":"PW Smith","year":"2009","unstructured":"Smith PW, Turza KC, Carte CO (2009) Bilateral adrenalectomy for refractory Cushing\u2019s disease: a safe and definitive therapy. J Am Coll Surg 208:1059\u20131064","journal-title":"J Am Coll Surg"},{"key":"394_CR67","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(52)90027-2","volume":"13","author":"D Plotz","year":"1952","unstructured":"Plotz D, Knowlton AI, Ragan C (1952) The natural history of Cushing\u2019s disease. Am J Med 13:597\u2013614","journal-title":"Am J Med"},{"issue":"3","key":"394_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2010-1942","volume":"96","author":"RN Clayton","year":"2011","unstructured":"Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing\u2019s disease over 50\u00a0years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96(3):1\u201311","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR69","first-page":"479","volume":"4","author":"J Extabe","year":"1994","unstructured":"Extabe J, Vazquez JA (1994) Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach. Clin Endocrinol 4:479\u2013484","journal-title":"Clin Endocrinol"},{"key":"394_CR70","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","volume":"92","author":"OM Dekkers","year":"2007","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van Aken MO, Voormolen KHC, Romijn JA (2007) Mortality in patients treated for Cushing\u2019s disease is increased, compared with patients treated for non-functioning pituitary macroadenomas. J Clin Endocrinol Metab 92:976\u2013981","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR71","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","volume":"89","author":"GD Hammer","year":"2004","unstructured":"Hammer GD, Tyrrel JB, Lamborn KR, Apllebury CD, Hannegan ET, Bell S, Rahal R, Lu A, Wilson CB (2004) Transsphenoidal microsurgery for Cushing\u2019s disease: initial outcomes and long-term results. J Clin Endocrinol Metab 89:6348\u20136357","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR72","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-130-10-199905180-00015","volume":"130","author":"B Swearingen","year":"1999","unstructured":"Swearingen B, Biller BM, Barker FG 2nd, Katznelson L, Grinspoon S, Klibanski A, Zervas N (1999) Long-term mortality after transsphenoidal surgery for Cushing\u2019s disease. Ann Intern Med 130:821\u2013824","journal-title":"Ann Intern Med"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-012-0394-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-012-0394-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-012-0394-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:04:16Z","timestamp":1593993856000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-012-0394-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,20]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["394"],"URL":"https:\/\/doi.org\/10.1007\/s11102-012-0394-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717647801.793102801","asserted-by":"object"}]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,20]]}}}